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Synopsis: Src family tyrosine kinases, in particular Hck, can induce an unconventional 
protein secretion (UPS) pathway leading to Golgi-bypass secretion of a 
transmembrane protein into extracellular vesicles (EV). These results reveal an 
iRhom-independent alternative secretion route for the proinflammatory protease 
TACE, and have general implications for understanding the regulation of UPS and 
EV biogenesis. ER = Endoplasmic reticulum. MVE = Multivesicular endosome. pTyr 
= phosphotyrosine. 
 
ABSTRACT 
When studying how HIV-1 Nef can promote packaging of the proinflammatory 
transmembrane protease TACE into extracellular vesicles (EV) we have revealed a novel 
tyrosine kinase-regulated unconventional protein secretion (UPS) pathway for TACE.  When 
TACE was expressed without its trafficking co-factor iRhom allosteric Hck activation by Nef 
triggered translocation of TACE into EVs. This process was insensitive to blocking of classical 
secretion by inhibiting ER to Golgi transport, and involved a distinct form of TACE devoid of 
normal glycosylation and incompletely processed for prodomain removal. Like most other 
examples of UPS this process was GRASP-dependent but was not associated with ER stress. 
These data indicate that Hck-activated UPS provides an alternative pathway for TACE 
secretion that can bypass iRhom-dependent ER to Golgi transfer, and suggest that tyrosine 
phosphorylation might have a more general role in regulating UPS. 
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INTRODUCTION 
Extracellular vesicles (EV) are a 
heterogeneous group of membraneous 
particles, including exosomes and shedding 
vesicles, and have recently emerged as 
important mediators of intercellular 
communication1,2. The biogenesis, 
composition, and functions of different 
classes of EVs differ greatly, but remain 
incompletely understood. EVs isolated from 
blood and other biofluids are considered as 
valuable sources of biomarkers for diagnosis 
and monitoring of various diseases, such as 
cancer.  
It is likely that EVs also serve as pathogenic 
mediators in many different types of 
disease3,4. EVs containing inflammation 
promoting factors can be found in the blood 
of HIV-infected individuals, and correlate with 
disease progression and poor recovery of the 
immune system following antiviral therapy5. 
A prominent component of circulating EVs 
collected from HIV-infected individuals is 
tumor necrosis factor-α conve ting enzyme 
(TACE), also known as a disintegrin and 
metalloproteinase 17 (ADAM17)6,7. Uploading 
of TACE into EVs is promoted by the HIV-1 
pathogenicity factor Nef via its interactions 
with cellular protein kinases8. In addition to 
its role in TNF release, TACE is responsible for 
proteolytic maturation of other cytokines, 
cytokine receptors, and extracellular matrix 
components involved in inflammation6,7. 
Thus, EV-associated TACE could be a key 
player in the chronic immune activation that 
drives AIDS pathogenesis and persistent viral 
replication.  
EVs have also been implicated in stimulated 
secretion of interleukin-1 (IL-1), a potent 
proinflammatory cytokine9 produced upon 
inflammasome activation by bacterial and 
viral infections, or endogenous danger signals 
like ATP and urate10. IL-1 lacks a signal 
sequence for targeting it to the conventional 
ER-Golgi secretion route, and instead 
represents a prominent example of a protein 
released via unconventional protein secretion 
(UPS)11. 
Several different types of UPS pathways exist 
and can be utilized as an alternative Golgi-
bypass secretion mechanism also by proteins 
having a canonical signal sequence12-14. A 
well-characterized example of this is the 
disease-ca sing va iant ΔF508-CFTR of cystic 
fibrosis transmembrane conductance 
regulator, which is functional as an ion 
channel, but is defective in its trafficking to 
the plasma membrane15. Recently Gee and 
coworkers showed that surface expression 
and thereby f nction of ΔF508-CFTR could be 
rescued in vitro as well as in a mouse model 
of cystic fibrosis by directing an immature 
core-glycosylated form of ΔF508-CFTR to the 
plasma membrane via an unconventional 
GRASP-dependent secretion route16.  
The Golgi reassembly stacking proteins 
GRASP55 and GRASP65 were originally 
identified as factors required for the stacking 
and integrity of Golgi cisternae17. However, 
GRASPs are largely dispensable for the 
conventional anterograde protein 
transport18,19, but instead have recently 
emerged as key factors in unconventional 
protein secretion that bypasses the Golgi20,21. 
In this study we have examined the role of 
Src family kinases in regulating uploading of 
TACE into EVs, which led us to identify a 
tyrosine phosphorylation-regulated and 
GRASP-dependent unconventional secretion 
pathway that enables vesicle secretion of 
TACE independently of its otherwise essential 
ER-Golgi trafficking co-factor iRhom2.   
 
RESULTS 
Src family tyrosine kinases can trigger TACE 
secretion into extracellular vesicles 
We have previously shown that Lck and Hck 
kinases are involved in HIV Nef-induced 
secretion of TACE into extracellular 
vesicles8,22. To test if this is a general property 
of Src family tyrosine kinases (SFK) we 
transfected TACE into human HEK293 cells 
alone or together with activated (Y-to-F 
change in the C-terminal Csk phosphorylation 
site) variants of human Lck, Hck, Lyn, Fgr, or 
Fyn. In order to monitor SFK catalytic activity 
in these cells a vector expressing paxillin, a 68 
kDa adaptor protein and SFK substrate23, was 
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also co-transfected and detected with regular 
or phospho-Y31-specific antibodies.  
As shown in Figure 1A, TACE was found in EV 
preparations from supernatants of all SFK-
transfected cells, but not from cells 
transfected with TACE in the absence of a SFK 
(correlating with the lack of paxillin Y31 
phosphorylation). Thus, at least in a tyrosine 
kinase overexpression model, triggering EV 
secretion of TACE is a property shared by 
different SFK members, and does not require 
ectopic expression of additional cellular or 
viral signaling factors.  
Among the SFK family Hck is potently and 
preferentially activated by HIV-1 Nef24,25. To 
generate a cell line model for studying TACE 
EV secretion caused by Nef-induced natural 
allosteric SFK activation, we transduced 
HEK293 cells with a lentiviral vector 
expressing wild-type human p59Hck. 
Individual clones were selected that 
expressed Hck at levels that were readily 
detectable but still subjected to efficient 
suppression of kinase activity by 
conformational autoinhibition, as indicated 
by the failure to phosphorylate residue Y31 of 
paxillin (Figure 1B).  
Similar to mock-transduced cells (puromycin 
selection marker only) these stably Hck-
expressing cells did not show any EV 
secretion of transfected TACE. However, 
when TACE was transfected together with 
Nef, robust paxillin-Y31 phosphorylation and 
EV secretion of TACE could be observed in 
Hck-transduced but not in mock-transduced 
cells (Figure 1B). Thus, similar to transient 
over-expression of SFK activity (Figure 1A), 
conformational activation of Hck mimicking 
the effects of Nef in HIV-infected cells can 
also efficiently activate EV secretion of TACE.  
Hck isoforms differ in their capacity to 
induce EV secretion of TACE 
In addition to the myristoylated and 
palmitoylated p59Hck an alternative p61Hck 
isoform exists, whose translation starts at a 
CTG codon upstream of the p59 ATG start 
site. p61Hck is also myristoylated but lacks 
the palmitoylation signal. These differing 
acylation signals have been shown to direct 
p59 and p61 preferentially to the plasma 
membrane and lysosomes, respectively26. 
We compared the capacity of the p59 and 
p61 isoforms to activate secretion of TACE 
into extracellular vesicles. As shown in Figure 
1C, only p59Hck activated TACE secretion, 
although both isoforms were expressed at 
comparable levels and similarly 
phosphorylated paxillin. An N-terminally 
epitope-tagged version of p59Hck lacking 
both acylation sites was also unable to induce 
TACE secretion, but could mediate low-level 
paxillin Y31 phosphorylation. Catalytically 
inactive Hck mutant K269N failed to activate 
TACE secretion, and as expected, was also 
completely deficient in paxillin 
phosphorylation. Thus, mere overexpression 
of Hck together with TACE does not induce 
secretion of TACE into EVs, and instead 
catalytic activity and proper membrane 
association domain is required for Hck to 
accomplish this.   
Inducible EV secretion involves 
hypoglycosylated TACE   
Although TACE was detected both in cell 
lysates and in EVs as a predominant doublet 
of bands in Western blotting we noted that 
the electrophoretic mobility of these two 
protein doublets were clearly different 
(approximately 130 and 105 kDa in cell 
lysates vs. 105 and 80 kDa in EVs; see Figure 
2A). The apparent molecular weight of TACE 
can vary depending on its glycosylation status 
27 and whether it has undergone proteolytic 
activation by furin-mediated removal of the 
N-terminal prodomain28,29. Therefore, we 
tested antibodies against the C-terminus or 
the N-terminus (prodomain) of TACE, and 
studied the effect of enzymatic 
deglycosylation on these TACE protein 
species. The 130 kDa species ("band A") that 
was found only in the cell lysates, as well as 
the 105 kDa species ("band B") that was 
present in the lysates and in the EVs could be 
detected either with an antibody targeting 
the TACE C-terminus or an antibody against 
the N-terminal prodomain, indicating that 
they had not been subjected to proteolytic 
activation. By contrast, the 80 kDa band 
("band C") that was found only in the EVs 
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could not be detected with the anti-
prodomain antibody, indicating that it 
represented a mature form of TACE lacking 
the autoinhibitory prodomain.  
When the cell lysates were treated with the 
glycosidases PNGase F or Endo H, the 130 kDa 
band disappeared, whereas the intensity of 
the 105 kDa species increased, indicating that 
bands A and B represented differentially 
glycosylated forms of the same polypeptide, 
i.e. prodomain-containing full-length TACE.  
By contrast, deglycosidase treatment had no 
effect on the mobility of the 105 kDa and 80 
kDa TACE bands detected in the EVs, 
indicating that they represented 
hypoglycosylated forms of TACE with and 
without the prodomain, respectively.  
Both PNGase F and Endo H can remove high-
mannose glycan modifications introduced in 
the ER, but following their further 
modification in the Golgi they become 
resistant to Endo H and can be cleaved only 
by PNGase F30. Whereas no mature TACE 
(lacking the prodomain) was seen in 
untreated cell lysates, a faint signal for the 80 
kDa band ("band C") could be detected after 
treatment with PNGase F (but not with Endo 
H). This indicated that a small amount 
proteolytically activated TACE was also 
present in the cells, but was not evident in 
the untreated lysates because it was 
glycosylated and therefore co-migrated with 
prodomain-containing, hypoglycosylated 
TACE species (band B). Thus, the prodomain-
containing 130 kDa TACE species in cell 
lysates was glycosylated only in an ER-specific 
manner, whereas the scarcely present 
prodomain-lacking form of TACE ("band-B*" 
as illustrated in Figure 2D) had undergone 
further glycosylation in the Golgi.  
However, the most important finding of these 
experiments was that neither PNGase F nor 
Endo H treatment changed the mobility of 
the prodomain-containing 105 kDa species or 
the proteolytically matured 80 kDa species of 
TACE in the EVs, thus showing that TACE 
secreted into extracellular vesicles is 
hypoglycosylated. 
To confirm that the 80 kDa TACE species in 
the EVs was indeed a product of prodomain 
cleavage at the furin target site we created a 
mutant form of TACE (TACE-FM) in which this 
furin cleavage site was disrupted by a KR214 to 
NG substitution28. Confirming our 
assumption, when EVs from cells expressing 
TACE-FM were purified and analyzed the 
mature 80 kDa isoform (band C) was absent 
and only the 105 kDa precursor form of TACE 
(band B) could be detected (Figure 2B). 
To study if the protease activity of TACE itself 
was relevant for EV secretion we also 
generated an inactive TACE mutant (TACE-
CD) carrying a previously described E406A 
substitution31 that disrupts its catalytic site. 
No difference in Hck-induced EV secretion 
was observed between this mutant and wild-
type TACE (Figure 2B).  
Vesicle secretion of TACE is not mediated by 
iRhom2 
The catalytically inactive members of the 
rhomboid family of proteases, iRhom1 and 
iRhom2, have been established as essential 
regulators of TACE maturation27,32,33 required 
for ER-to-Golgi trafficking and subsequent 
cleavage of the prodomain of TACE. More 
recently, it was shown that iRhom2 regulates 
TACE throughout its lifecycle, and remains 
stably associated with TACE all the way 
through the secretory pathway34. Thus, 
overexpression of TACE alone in transfected 
HEK293 cells could be expected to result in a 
relative iRhom deficiency and a failure of the 
majority of cellular TACE to traffic and mature 
normally.  
To further substantiate the idea that Hck-
activated EV export of TACE was not iRhom-
regulated we examined the effects of RNAi-
mediated knock-down of iRhom2 expression 
as well as overexpression of iRhom2 together 
with TACE. We found that despite a potent 
suppression of iRhom2 expression in shRNA-
transduced cells compared to the parental 
HEK293 cells, secretion of TACE into EVs was 
equally robustly activated by Hck in both cells 
(Figure 3A).  
To overexpress iRhom2 we co-transfected the 
HEK293 cell with a vector for iRhom2-eGFP. 
Of note, this vector has been previously 
shown to encode a functional iRhom2 
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protein35, and it is known that addition of 
multiple epitopes tags at the C-terminus of 
iRhom2 does not affect its function as a 
transport/maturation co-factor and regulator 
of TACE34.  
Co-transfection of the iRhom2-GFP vector led 
to robust iRhom2 overexpression, but instead 
of promoting export of TACE into EVs, this 
resulted in a striking loss of TACE from the 
EVs (Figure 3B). Overexpression of iRhom2 
caused no apparent change in the proteolytic 
maturation or glycosylation pattern (i.e. 
electrophoretic mobility) of TACE, suggesting 
that proper trafficking of TACE through the 
trans-Golgi network might require additional 
co-factors whose expression in HEK293 cells 
become limiting in this setting.  
In any case, we conclude that tyrosine 
phosphorylation-regulated uploading of TACE 
into vesicles is active when TACE is 
transfected alone, whereas co-expression of 
iRhom2 directed TACE to a different fate. On 
the other hand, export of TACE into EVs is not 
affected by potent knock-down of iRhom2 
expression. Thus, Hck-activated EV secretion 
provides an iRhom-independent, alternative 
exocytosis pathway for TACE. 
EV secretion of TACE is independent of 
anterograde transport from the ER to the 
Golgi 
The hypoglycosylated status of TACE 
uploaded into the EVs, and the independence 
of this process from the TACE trafficking co-
factor iRhom suggested involvement of an 
unconventional secretion pathway. To test 
this idea, we treated the cells with brefeldin 
A (BFA), an inhibitor of the guanine 
nucleotide exchange factor GBF136 that has 
been widely used to inhibit protein transport 
from ER to Golgi. 
We found that BFA treatment failed to 
prevent EV secretion of TACE triggered by 
Nef-mediated Hck activation in stably Hck-
expressing cells (Figure 4A), although it 
efficiently inhibited trafficking of the 
multivesicular body (MVB)-derived exosome 
marker LAMP-1 into vesicles (Figure 4B). Of 
note, EV secretion of LAMP-1 was 
constitutive, and not positively or negatively 
regulated by Hck activation.  
To ensure that the failure of BFA to block 
export of TACE into EVs was not due to an 
incomplete pharmacological effect we also 
tested a 10-fold higher concentration (2 
µg/ml) of BFA and obtained identical results 
(Figure S1A). In addition, we verified the 
continued effectiveness of 200 ng/ml BFA 
treatment during the entire EV harvesting 
period by using confocal fluorescent 
microscopy to confirm a complete absence of 
normal Golgi morphology in these cells 
(Figure S1B). 
Secretion of LAMP-1 into extracellular 
vesicles was also blocked by tunicamycin (an 
inhibitor of N-glycosylation) and significantly 
reduced by thapsigargin (an inhibitor of 
sarco/endoplasmic reticulum Ca2+-ATPase), 
two agents that disturb ER function and 
induce ER stress37 (Figure 4B). By contrast, 
Hck-activated EV secretion of TACE was not 
affected by treatment of the cells with 
tunicamycin or thapsigargin (Figure 4A). Thus, 
we conclude that secretion of TACE into 
extracellular vesicles is mediated by an 
unconventional pathway that is not affected 
by ER dysfunction and does not involve 
anterograde vesicular transport of proteins 
from ER to Golgi, a key step in canonical 
protein secretion.  
Of note, whereas blocking of conventional ER 
to Golgi-mediated secretion did not abolish 
vesicle secretion of TACE, it resulted in a 
specific disappearance of the proteolytically 
matured 80 kDa TACE species from the EVs 
(Figure 4A ). This indicates that in order for 
unconventionally secreted TACE to be 
activated by prodomain removal it must meet 
at some point along its way with furin or a 
furin-like protease that is trafficked via the 
conventional secretion pathway.  
Inducible EV secretion of TACE is not 
mediated by ER stress 
A feature shared by many different types of 
unconventional protein secretion is that 
these pathways are activated by ER stress13. 
Therefore, whereas ER malfunction/stress did 
not prevent tyrosine kinase-activated EV 
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secretion of TACE, it is also important to note 
that in the absence of Hck activation (when 
TACE was transfected without Nef) BFA, 
tunicamycin, or thapsigargin treatment alone 
did not induce secretion of TACE into vesicles 
without Hck activation (Figure 4A). 
To confirm that treatment with these 
compounds did indeed induce ER stress we 
monitored changes in XBP1 mRNA splicing in 
these cells. As shown in Figure 4C, BFA and 
thapsigargin activated XBP1 mRNA splicing, 
an established outcome and reporter of ER 
stress37. By contrast co-transfection of TACE 
together with Hck did not result in a change 
in XBP1 mRNA splicing. Thus, we conclude 
that induction of ER stress does not trigger 
unconventional secretion of TACE, and 
conversely, tyrosine phosphorylation-induced 
EV secretion of TACE was not associated with 
ER stress.      
Hck-induced EV secretion of TACE is 
GRASP55-dependent 
Many unconventional protein secretion 
pathways have been found to involve the 
GRASP-family proteins21. We therefore used 
the CRISPR/Cas9 technology to knock out 
GRASP55 expression in HEK293 cells. In 
contrast to control cells the GRASP55-KO cells 
failed to secrete TACE into EVs upon 
overexpression of Hck activity (Figure 5A). 
The failure to upload TACE into EVs was not 
associated with obvious abnormalities in the 
subcellular localization, as a very similar TACE 
immunostaining pattern with an extensive co-
localization with a fluorescent ER marker 
protein was seen both in wild-type and 
GRASP55-KO HEK293 cells (Figure S2).  
Endogenous GRASP65 protein was 
abundantly expressed both in control and 
GRASP55-KO cells, indicating that these two 
GRASP proteins serve non-redundant roles 
regarding inducible protein secretion into 
EVs. Indeed, when similar knock-out 
experiments were carried out to examine the 
role of GRASP65, only a very modest or no 
reduction in Hck-activated EV export of TACE 
was observed (Figure 5B).  
In addition, we found that overexpression of 
GRASP55 but not GRASP65 could efficiently 
trigger EV secretion of TACE also in the 
absence of Hck activation (Figure 5C). Thus, 
while the mechanistic role of GRASP proteins 
in this process remains to be further 
elucidated, we conclude that similar to 
previously reported other unconventional 
secretion pathways21, tyrosine kinase-
activated secretion of TACE into extracellular 
vesicles requires GRASP55. 
TACE-containing EVs are produced by an 
nSmase2-dependent exosome pathway 
The two principal classes of EVs are named 
exosomes and ectosomes. Exosomes are 
derived from intraluminal vesicles of multi-
vesicular endosomes (MVE) following fusion 
of the MVE with the plasma membrane, 
whereas ectosomes are shedding vesicles 
that assemble and bud at the plasma 
membrane38. Ceramide is involved in MVE 
formation, and since the original study by 
Trajkovic et al39 the inhibition of neutral 
sphingomyelinase-2 (nSmase2) to block 
ceramide synthesis has been widely used to 
interfere with exosome production. By 
contrast, nSmase2 inhibition does not 
prevent and can instead enhance the 
production of ectosomes40.  
In order to characterize the origin of the EVs 
involved in Hck-activated vesicle secretion of 
TACE we generated knock-down derivatives 
of HEK293 cells in which nSmase2 expression 
had been suppressed by lentivirally delivered 
shRNAs. We found that similar to the 
spontaneous EV secretion of LAMP-1, Hck-
activated packaging of TACE into EVs was 
almost completely blocked as a consequence 
of the Smase2 knock-down (Figure 6). By 
contrast, the EV association of HIV-1 Nef, a 
myristoylated membrane-targeted protein, 
was not at all affected by nSmase2 knock-
down, suggesting that it was mainly 
associated with ectosomes.  
Thus, we conclude that Hck-activates 
packaging of TACE into exosome-like vesicles 
that are derived from intraluminal vesicles of 
MVE rather than by budding directly from the 
plasma membrane.  
DISCUSSION 
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Signal peptide-containing proteins are 
traditionally thought to reach their final 
destinations by trafficking via the classical ER 
to Golgi early secretory pathway41. However, 
secretion of transmembrane proteins via a 
Golgi-bypass mechanism has also been 
described, which together with pathways for 
secretion of cytoplasmic proteins is known as 
unconventional protein secretion (UPS)12-14,42. 
Our interest in understanding how HIV-1 Nef 
can stimulate packaging of the immune 
regulator TACE into extracellular vesicles has 
now revealed a novel tyrosine kinase-
regulated UPS mechanism for TACE secretion. 
Characteristic of UPS, Hck-triggered delivery 
of TACE into EVs could not be blocked by 
brefeldin A, whereas this inhibitor of ER-to-
Golgi transport effectively blocked 
incorporation of LAMP-1 into EVs. Also, 
compared to the cellular pool of TACE EV-
resident TACE was distinctly 
hypoglycosylated, and did not change its 
electrophoretic mobility by a deglycosidase 
treatment.    
Normal trafficking and proteolytic maturation 
of TACE depend on iRhom1/2, catalytically 
inactive members of the rhomboid-like 
superfamily that serve as chaperones or 
regulatory subunits controlling ER-to-Golgi 
transport as well as subsequent fate of 
TACE34,43.  Thus, tyrosine phosphorylation-
regulated UPS can provide an alternative, 
iRhom-independent secretion route for TACE. 
It is interesting to note that also previous 
examples of transmembrane proteins 
identified as clients of UPS are similarly 
restricted in moving from ER to Golgi because 
of the lack of a relevant binding partner or a 
mutation that interferes with folding. 
Specifically, under certain conditions 
Drosophila -integrins are secreted via a 
Golgi-bypass mechanism without 
heterodimerization with a  subunit44,45. On 
the other hand, the most common cystic 
fibrosis-ca sing m tation ΔF508-CFTR results 
in ER accumulation because of impaired 
folding15, which can be circumvented by 
activating trafficking to the plasma 
membrane via UPS16. Similarly, the 
predominant H723R mutation of pendrin 
(causing hearing loss and Pendred syndrome) 
leads to defects in folding and cell-surface 
expression of pendrin, which can be rescued 
by HSP70 co-chaperone DNAJC14-dependent 
UPS46. It should be noted, however, that 
certain transmembrane proteins may also use 
UPS as their regular mode of trafficking 
route12,47,48.  
While overall UPS-mediated trafficking of 
hypoglycosylated TACE into EVs was not 
prevented by brefeldin A treatment, such 
inhibition of ER to Golgi transfer caused a 
specific loss of proteolytically matured TACE 
species from the EVs. Removal of the TACE 
prodomain is catalyzed by the proprotein 
convertase furin28,29, which is acting in the 
trans-Golgi network (TGN) and subsequent 
endosomal compartments49. Thus, in order 
for the prodomain cleavage to occur the 
Golgi-bypass UPS pathway utilized by TACE 
must converge with trafficking of furin in a 
post-Golgi MVB-like endosomal compartment 
where the extracellular vesicles containing 
proteolytically matured but hypoglycosylated 
TACE originate from. It would be interesting 
to examine whether this compartment is 
related to the syntaxin 13-containing 
endosomes involved in unconventional 
plasma membrane trafficking of CFTR 
described by Yoo et al50. Regardless of the 
identity of this vesicular compartment, the 
fact that furin can recognize and remove the 
prodomain of the hypoglycosylated TACE 
suggests that it has been properly folded. This 
is in agreement with the work of Adrain et al. 
who found that inactive TACE 
immunopurified from cells lacking iRhom 
could be converted to a fully active TNF-
processing enzyme by removal of its 
prodomain with recombinant furin27.  
Similar to most21 but not all51 UPS pathways 
tyrosine kinase triggered EV secretion of 
TACE was found to be GRASP-dependent. 
TACE secretion was not observed in cells 
where GRASP55 was inactivated, and 
interestingly, could also be elicited in the 
absence of tyrosine kinase activation by 
forced GRASP55 overexpression. However, in 
contrast to most reported forms of UPS, 
including Golgi-bypass sec etion of ΔF508-
CFTR UPS16, tyrosine phosphorylation-
regulated routing of TACE from ER into EVs 
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was not triggered by ER stress. The effect of 
Hck activation could not be mimicked by 
compounds that induce ER stress by various 
mechanisms, and no ER stress could be 
observed in cells with activated Hck. Thus, Src 
family tyrosine kinase activation can trigger a 
distinct type of UPS response with similarities 
as well as differences compared to the 
previously characterized unconventional 
secretion pathways.  
It will be interesting and informative to 
identify the specific substrate(s) of tyrosine 
phosphorylation that activate this novel UPS 
pathway. Our preliminary results indicate 
that the cargo, i.e. TACE itself, is not tyrosine 
phosphorylated (ZZ, unpublished). It has been 
previously shown that Hck activation can 
modulate Golgi function and affect 
glycosylation and trafficking of colony 
stimulating factor-1 receptor (M-CSFR/Fms), 
which was associated with phosphorylation 
of Erk1 at Tyr204 and GRASP65 at Ser27752. 
Src kinases can stimulate the MAPK pathway 
in several ways, including phosphorylation of 
residues Y340 and Y341 of Raf-153, which 
leads MEK1/2-mediated activation of 
Erk1/254. On the other hand, Erk kinases are 
known to regulate Golgi dynamics via GRASP 
serine phosphorylation55-57. Thus, Erk kinases, 
especially the Golgi-associated Erk1c 
isoform58, seem like good candidates for 
downstream mediators of Hck in activating 
EV secretion of TACE. In support of this 
possibility we observed that this process can 
be blocked using the specific MEK1/2 
inhibitor U0126 (ZZ, unpublished).  
Further molecular characterization and 
comparison of UPS triggered by Src family 
tyrosine kinases with other unconventional 
secretion pathways, as well as identification 
of other proteins secreted to EVs, plasma 
membrane, or extracellular space via 
phosphotyrosine-regulated UPS are all areas 
that would need additional clarification. The 
importance of TACE in regulating 
inflammation and immunity, the ubiquitous 
involvement of Src family kinases in the 
development of cancer, as well as the 
emerging roles of extracellular vesicles in 
normal physiology and different pathological 
conditions suggest that such studies would be 
worthwhile topics for future research.  
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MATERIALS AND METHODS 
Reagents and antibodies 
The details and vendors of the reagents and 
antibodies used in this study were the 
following. 1,10-phenanthroline, tunicamycin, 
thapsigargin and brefeldin A (Sigma Aldrich); 
Endoglycosidase H (Endo H) and Peptide-N-
Glycosidase F (PNGase F) (New England 
Biolabs); protease and phosphatase inhibitor 
(Thermo Fisher Scientific). Mouse anti-
GAPDH (MAB374, EMD Millipore), mouse 
anti-Myc (SC-40, Santa Cruz Biotechnology), 
mouse anti-TACE cyto-domain (MAB2129, 
R&D systems), rabbit anti-TACE pro-domain 
(ab39161, Abcam), rabbit anti-paxillin (SC-
5574, Santa Cruz Biotechnology), mouse anti- 
pY31 paxillin (BD Biosciences), rabbit anti-Hck 
(SC-72, Santa Cruz Biotechnology), mouse 
anti-α-tubulin (T9026, Sigma-Aldrich), rabbit 
anti-GRASP65 (ab174834, Abcam), rabbit 
anti-GRASP55 (ab209338, Abcam), sheep 
anti-Nef (Targeted Affinity Oy, Helsinki, 
Finland), rabbit anti  iRhom2 Antibody (PA5-
48602, Invitrogen). Streptavidin IRDye680CW, 
Streptavidin IRDye800CW, IRDye680CW goat 
anti-mouse IgG and IRDye800CW goat anti-
rabbit IgG were from LI-COR Biotechnology. 
Alexa Fluor 488 secondary antibody and 
P oLong™ G ass Antifade Mo ntant with 
N cB  e™ Stain we e f om Invit ogen. 
Plasmids 
pRK5M-TACE was from Rik Derynck (Addgene 
plasmid # 31714), and TACE K213N/R214G, 
E406A mutations were created to the same 
vector background.  pmCherry-N1-GalT was 
from from Lei Lu (Addgene plasmid # 87327). 
HIV-1(SF2) Nef (P03407) coding sequence 
was cloned into pEF vector (Invitrogen). 
Mouse iRhom2, human GRASP55, GRASP65, 
and LAMP-1 cDNAs were obtained from 
Genome Biology Unit core facility (University 
of Helsinki, Finland). iRhom2 was cloned into 
pEGFP-N1 vector; GRASP55, GRASP65, LAMP-
1 and paxillin cDNAs were cloned into pEBB 
vector59 with a C-terminal myc-tag. To create 
the pWPI-puro vector we replaced EGFP in 
pWPI-EGFP (from Didier Trono; Addgene 
plasmid # 12254) with the puromycin 
resistance gene. Human Hck p59 cDNA 
(isoform b / NP_001165604) was cloned into 
pEBB and pWPI-puro vectors. We added an 
N-terminal HA-tag with Hck, created an Hck 
K269N mutation or added a longer N-
terminus corresponding to Hck p61 (isoform a 
/ NP_002101). Constitutively active mutants 
of human Hck p59, Lyn, Lck, Fyn and Fgr were 
generated by changing their C-terminal Csk 
target tyrosine residues (corresponding to 
Y530 in c-Src) into a phenylalanine, and the 
mutant forms were cloned into pEBB 
together with a 123 aa biotin acceptor 
domain fused to their C-termini60. gRNA 
expression plasmids for GRASP55 and 
GRASP65 knock-out, and shRNA expression 
plasmids for iRhom2 and nSMase2 knock-
down were from Biomedicum Functional 
Genomics Unit (University of Helsinki, Finland) 
and CAG-Cas9-T2A-EGFP-ires-puro was from 
Timo Otonkoski (Addgene plasmid # 78311). 
The ER marker mCherry-KDEL was generated 
by replacing the BFP of Addgene plasmid 
#49150 from Gia Voeltz with mCherry. All 
mutants were created by standard overlap 
PCR mutagenesis. All plasmid constructs were 
verified by DNA sequencing or restriction 
enzyme digestion. 
GRASP knock-out cells 
HEK293 cells were maintained in high-glucose 
DMEM (Sigma), supplemented with 10% FBS, 
0.05 mg/ml penicillin and 0.05 mg/ml 
streptomycin (cell culture media). Cells were 
plated in 6 well plates for around 80% 
confluence after 24 hours. Cells were co-
transfected with 0.5 μg Cas9 plasmid and 1.5 
μg pKLV-puro plasmid containing gRNA 5’-
CCTTTCTTTGATTTTATTGTTTC-3’ ta geting the 
second exon of the human GRASP55 gene 
(NM_015530) o  gRNA (5’-
GAGAAATTCCCGACACGTCCAGG-3’) 
expression pKLV-puro plasmid targeting the 
eighth exon of human GRASP65 gene 
(NM_031899) in Opti-MEM medium (Gibco) 
with 6 μg po yethy enimine (PEI). In gene a , 
μg DNA:μg PEI was 1:3 in tota  50 μ  of Opti-
MEM per well. 48 hours post-transfection, 
cells were selected with 6 µg/ml puromycin 
for 2 days, then diluted and seeded in 96-well 
plates for single cell selection.  
Lentiviral transduction of HEK293 
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HEK293 cells were cultured in 6 well plates 
and co-transfected with 2.5 µg pDelta8.9, 1.5 
µg VSV-G, 3 µg pWPI-puro plasmid containing 
human Hck-p59, iRhom2 or nSMase2 shRNA 
expression pLKO.1 plasmid in Opti-MEM 
medi m with 12 μg PEI. Afte  5 hours, 
medium was refreshed with cell culture 
media. After 48 hours, medium was collected 
and purified via 0.22 µm filter, then added to 
fresh HEK293 cells. After 24 hours, 
transduced cells were selected with 6 µg/ml 
puromycin for 2 days. 
Deglycosylation analyses 
HEK293 cells were collected and lysed on ice 
for 10 minutes in lysis buffer (150 mM NaCl; 
50 mM Tris–HCl, pH 7.4; 1% NP40, containing 
10 mM 1, 10-phenanthroline, protease and 
phosphatase inhibitor cocktail), and 
centrifuged at 16,000g at 4℃ to obtain post-
nuclear supernatants. Subsequently the 
lysates were denatured at 90℃ and treated 
with Endo H or PNGase F according to the 
man fact  e ’s inst  ctions. 
Isolation of EVs 
48 hours post-transfection, 12 ml 
supernatants were collected and centrifuged 
for 10 min at 1,000 g, 30 min at 10,000 g and 
ultra-centrifuged for 90 min at 100,000 g. 
Pellets were resuspended in 100 µl 1 x SDS 
PAGE sample buffer as EV preparations. For 
N-glycosylation study, EV pellets were 
resuspended in 10 ml PBS and ultra-
centrifuged again at 100,000 g for 90 min, 
and solubilized in 30 µl lysis buffer for further 
de-glycosylation analysis. 
XBP1 splicing  
Total cellular RNA was isolated using the 
RNeasy Mini kit (Qiagen), including DNase 
digestion (RNase free DNase kit; Qiagen). 500 
ng of total RNA was transcribed to cDNA 
using the TaqMan reverse transcriptase kit 
(Applied Biosystems). Subsequently, 1μl of 
diluted cDNA template (20 ng) was mixed 
with 200 μM of each dNTP, 300 nM forward 
(5´-TTA CGA GAG AAA ACT CAT GGC C-3´) and 
reverse (5´- GGG TCC AAG TTG TCC AGA ATG 
C -3´) primers, 5 μl 10 × optimized DyNAzyme 
buffer (F-511, Thermo), 1 μl DyNAzyme II 
DNA polymerase (Thermo), and nuclease-free 
water to a total volume of 50 μl. The PCR 
cycle starts with a 1 min incubation at 94 °C, 
then 35 cycles for 1 min at 94°C, 1 min at 54 
°C, and 1 min at 72 °C; this is followed by a 
final incubation at 72 °C for 10 min. PCR 
products were separated by electrophoresis 
on a 3% agarose gel and visualized by Midori 
Green Advance DNA staining (Nippon 
Genetics Europe).  
Immunoblots 
SDS gel electrophoresis and Western blotting 
were carried out following standard 
procedures and using IRDye-labeled 
detection reagents. The blots were visualized 
and the signals quantified using the Odyssey 
infrared imaging system and Image Studio 
v3.1. software (LI-COR Biosciences, Lincoln, 
NE, USA). All protein blotting results shown 
are representative of at least three 
comparable independent experiments. 
Microscopy 
Cells were plated on 13mm #1.5 coverslips 
24h before transfection. After indicated times 
the cells were fixed with 4% PFA for 15min, 
washed two times with PBS+0.2% BSA and 
permeabilized with 0.2% for 10min followed 
by washing two times with PBS+0.2% BSA. 
The cells were stained with c-Myc Antibody 
(sc-40) for TACE in PBS containing 0.2% BSA 
at 37C for 45min. Cells were washed and 
stained with secondary antibody Alexa Fluor 
488 (Invitrogen) as described above. After 
washing the cells, the coverslips were 
mounted on a microscope slides with 
P oLong™ G ass Antifade Mountant with 
N cB  e™ Stain (Invitrogen). The cells were 
visualized under Zeiss LSM 780 Confocal 
microscope. 
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FIGURE LEGENDS 
 
Figure 1. SFK activation induces TACE 
secretion into EVs. (A.) HEK293 cells were 
transiently transfected with TACE, paxillin, 
dominantly active Hck, Lyn, Lck, Fyn or Fgr. 
Lysates of the transfected cells (Cell) and EV 
preparations (EV) isolated from their culture 
supernatants were subjected to Western 
blotting using the indicated antibodies. The 
TACE antibody used was against the C-
terminal tail. The SFKs were fusion proteins 
containing a biotin acceptor domain and 
were detected using labeled streptavidin. 
Even loading of EV preparations was 
demonstrated by probing the blots with an 
anti-tubulin antibody. (B.) Mock-transduced 
control cells (Stable Hck: -) or HEK293 cells 
stably expressing native Hck-p59 (Stable Hck: 
+) were transfected with TACE, Nef, and 
paxillin as indicated, and analyzed as in A. 
(C.)  HEK293 cells were transfected with TACE 
and Hck-p59, catalytically inactive mutant of 
Hck-p59 (KD), N-terminally HA-tagged Hck-
p59 (N-HA), or Hck-p61, and analyzed as in A. 
Quantification of the relative intensities of 
the specific protein signals are indicated 
under the blots.  
 
 
 
Figure 2. Characteristics of TACE species 
found in cell lysates and in EVs. (A.) Cell 
lysates and EVs preparations from cells co-
transfected with TACE and Hck-p59 were 
deglycosylated with Endo H (H), PNGase F (F) 
or left untreated (c) and examined by 
Western blot analysis using antibodies 
targeting the C-te mina  tai  (α-C-term.) or 
the N-te mina  p odomain (α-prodom.) of 
TACE. The deduced prodomain composition 
and glycosylation status of the observed 130 
kDa, 105 kDa, and 80 kDa species of TACE 
(indicated by arrows A, B, and C, 
respectively) are illustrated on the right. Of 
note, unglycosylated prodomain-containing 
TACE ("Species B") and mature TACE 
(glycosylated in a Golgi-specific manner and 
lacking the prodomain; "Species B*") co-
migrate within the band indicated by arrow 
B. (B.) Cell lysates and EVs preparations from 
cells transfected with Hck-p59 alone (-) or 
together with wild-type (WT) or 
K213N/R214G (FM) or E406A (CD) mutants of 
TACE were examined by Western blot 
analysis using antibodies against the C-
terminus or the prodomain of TACE. Even 
loading of cell lysates and vesicle 
preparations was demonstrated by probing 
the blots with an anti-tubulin antibody. 
Quantification of the relative intensities of 
the specific protein signals are indicated 
under the blots. 
 
 
Figure 3. TACE vesicle secretion is 
independent of ER to Golgi trafficking and 
ER stress.  (A.) HEK293 cells stably expressing 
native Hck-p59 were transfected with TACE 
alone or in combination with HIV-1 Nef, a 
potent allosteric activator or Hck. After 5 h 
the transfected cultures were treated with 4 
µg/ml tunicamycin (Tun), 200 ng/ml brefeldin 
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A (BFA), 500nM thapsigargin (TG) for 36 h or 
left untreated (-), followed by Western 
blotting analysis of TACE and Nef expression 
in lysates of these cells, and TACE in EVs in 
their culture supernatants. (B.)  Stably Hck-
p59 expressing cells were transfected and 
examined exactly as in Figure 3A, except that 
instead of TACE now LAMP-1 was transfected 
and detected by Western blotting. (C.) 
HEK293 cells were transfected with TACE 
and/or Hck, and starting at 5 h post-
transfection treated for 24 h with brefeldin A 
or thapsigargin, or left untreated before 
lysates of these cells were analyzed by 
Western blotting for the expression of 
transfected TACE and Hck, and endogenous 
GAPDH proteins, and examined by RT-PCR 
for ER stress-associated alternative splicing of 
a short intron in XBP1 mRNA, which is 
indicated by the appearance of a 255 bp RT-
PCR product (black arrow) and disappearance 
of the 257 bp product (white arrow). 
Quantification of the relative intensities of 
the specific protein signals are indicated 
under the blots. 
 
 
Figure 4. Hck-induced TACE secretion into 
EVs involves GRASP55. (A. and B.) TACE 
and/or Hck-p59 were transfected into wild-
type (WT), GRASP55 knock-out (KO) or 
GRASP65 knock-out (KO) HEK293 cells as 
indicated. Lysates of these cells were 
analyzed by Western blotting for the 
expression of endogenous GRASP55 and 
GRASP65 and for transfected TACE and Hck 
proteins. EVs secreted by these cells were 
examined for their TACE content.  (C.) TACE 
was transfected into HEK293 alone (-) or 
together with Myc-tagged GRASP55 or 
GRASP65. Lysates of these cells were 
analyzed for the expression of the 
transfected TACE, Hck, and GRASP65/55 
proteins, and the EV preparations from these 
cultures were probed with antibodies against 
TACE and tubulin. Quantification of the 
relative intensities of the specific protein 
signals are indicated under the blots. 
 
 
Figure 5. Hck-activated export of TACE into 
EVs is not mediated by iRhom2. (A.) TACE 
was transfected alone (-) or together with 
Hck (+) into wild-type (WT) or iRhom2 knock-
down (KD) HEK 293 cells as indicated. Lysates 
of these cells were analyzed by Western 
blotting for the expression of endogenous 
iRhom2 and for the transfected TACE and 
Hck proteins. EVs secreted by these cells 
were examined for their TACE content. (B.) 
TACE was transfected alone or in 
combination with Hck and/or iRhom2 as 
indicated. Lysates of the transfected cells 
were examined by Western blotting to 
confirm proper TACE, Hck, and iRhom2 
expression. EV preparations from these cells 
were blotted with antibodies against TACE 
(anti-C-terminus) or tubulin as a vesicle 
protein loading control. Quantification of the 
relative intensities of the specific protein 
signals are indicated under the blots. 
 
 
Figure 6. Production of TACE-containing 
vesicles requires nSmase2 activity. Wild-
type (WT) and nSMase2 knock-down (KD) 
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HEK293 cells were transfected with TACE 
plus Hck, myc-tagged LAMP-1, or GFP-tagged 
Nef as indicated. Lysates of these cells were 
analyzed by Western blotting for expression 
of the transfected proteins. EV preparations 
from these were examined for their TACE, 
LAMP-1, or Nef content, and for tubulin as a 
vesicle protein loading control. 
Quantification of the relative intensities of 
the specific protein signals are indicated 
under the blots. 
 
 
 
Figure S1. BFA-resistance of Hck-activated 
export of TACE is not due to an incomplete 
pharmacological effect of BFA. (A.) TACE 
and/or Hck-p59 were transfected into wild-
type HEK293 cells as indicated. After 5 h the 
transfected cultures were supplemented 
with 0.2 µg/ml or 2 µg/ml BFA for 24 h or left 
untreated (-), followed by Western blotting 
analysis of TACE and Hck expression in these 
cells, and TACE in the EVs in their culture 
supernatants. Quantification of the relative 
intensities of the specific protein signals are 
indicated under the blots. (B.) HEK293 cells 
were cotransfected with TACE and a vector 
encoding a red fluorescent Golgi marker 
(β1,4-galactosyltransferase fused to 
mCherry; GalT-mCherry). After incubation for 
24 h with 0.2 µg/ml of BFA (or no treatment) 
the Golgi morphology in the transfected cells 
was examined by confocal 
immunofluorescence microscopy imaging 
(red signal). The nuclei were visualized using 
NucBlue stain (blue signal). A scale bar of 10 
µm is shown.  
 
Figure S2.  TACE is localized predominantly 
in the ER both in wild-type and in GRASP55-
deficient HEK293 cells. Parental (WT) and 
GRASP55 knock-out (KO) HEK293 cells were 
transfected with the ER marker mCherry-
KDEL and with Myc-tagged TACE. 24h post-
transfection the cells were fixed and 
examined by confocal fluorescence 
microscopy imaging for TACE 
immunostaining (anti-TACE; green) and ER 
marker fluorescence (mCherry-KDEL; red).  
An overlay of these signals is shown in the 
bottom panel (Merge; yellow).  A scale bar of 
5 µm is shown. 
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